Analyst firms · Wedbush · RZLT

Wedbush RZLT price target and rating history

Rezolute Inc. (RZLT) · Health Care

Wedbush rates Rezolute Inc. (RZLT) Outperform with a $5 price target, as of its latest action on Mar 25, 2026. It has published 3 rating actions on RZLT since November 2024, including 1 upgrade and 1 downgrade. Across 4 firms with a RZLT price target in the last 12 months, the median target is $8. Wedbush's $5 is 37% below that.

Current rating
Outperform
Price target
$5
Median target, all firms
$8
Actions on RZLT
3

Wedbush price target on RZLT

$12$6.50$120252026
Wedbush price target on RZLT, each point a stated target, November 2024 to March 2026.

Every Wedbush rating on RZLT

How other firms rate RZLT

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Cantor FitzgeraldOverweightOct 6, 2026
Lake StreetBuy$9Sep 30, 2026
Craig-HallumBuy$7Sep 29, 2026
Citizens JMPMkt Outperform$11Jun 3, 2026
WedbushOutperform$5Mar 25, 2026

Questions about Wedbush and RZLT

What is Wedbush's price target for RZLT?
Wedbush's latest stated price target for Rezolute Inc. (RZLT) is $5, from its action on Mar 25, 2026.
What is Wedbush's rating on RZLT?
Wedbush rates RZLT Outperform, a bullish rating, as of Mar 25, 2026.
When did Wedbush last change its view on RZLT?
On Mar 25, 2026, Wedbush upgrades to Outperform from Neutral, price target $5.
How does Wedbush's RZLT target compare with other analysts?
Across 4 firms with a RZLT price target in the last 12 months, the median target is $8. Wedbush's $5 is 37% below that.

More RZLT rating histories

All Wedbush ratingsRZLT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.